Related Experiment Videos
Blood transfusion has no effect on colorectal cancer survival. A population-based study
Insights
Perioperative blood transfusion in colorectal cancer surgery does not appear to negatively impact patient survival. This study found no adverse effect on survival rates for patients receiving blood transfusions during radical surgery.
Area of Science:
- Oncology
- Surgical Oncology
- Hematology
Background:
- Perioperative blood transfusions are common in major surgeries.
- The impact of these transfusions on long-term survival in colorectal cancer patients is debated.
- Understanding transfusion effects is crucial for optimizing cancer patient outcomes.
Purpose of the Study:
- To evaluate the association between perioperative blood transfusion and survival in colorectal cancer patients.
- To identify prognostic factors influencing survival in this patient cohort.
- To determine if blood transfusion adversely affects survival after radical colorectal cancer surgery.
Main Methods:
- Retrospective analysis of 698 colorectal cancer patients undergoing radical surgery.
- Data linkage with local cancer registry and blood bank records for transfusion status.
- Statistical analysis using relative risk (RR) and confidence intervals (CI), adjusting for prognostic factors like age, Dukes stage, and tumor location.
Main Results:
- Dukes B and C stages showed increased relative risk for mortality compared to Dukes A.
- Rectal tumors had a higher relative risk for mortality compared to right colon tumors.
- After adjusting for prognostic factors and excluding operative mortality, the relative risk for transfused patients was 1.16 (95% CI 0.87-1.55), indicating no significant adverse impact.
Conclusions:
- Perioperative blood transfusion is not associated with adverse survival outcomes in colorectal cancer patients.
- Prognostic factors such as Dukes stage and tumor location are significant predictors of survival.
- This study suggests that blood transfusions can be safely administered to colorectal cancer patients without compromising long-term survival.
Abstract:
This study was conducted to evaluate the impact on survival of perioperative blood transfusion in a series of 698 colorectal cancer patients undergoing radical surgery. Patients were identified, and follow-up was carried out by the local population-based cancer registry. Data on blood transfusion was obtained by record linkage with the files of the blood banks operating in the area covered by the registry. Prognostic factors were age, Dukes stage and topography of the primary tumour. Relative risk (RR) for Dukes B patients was 1.53 [95% confidence interval (CI) 0.94-2.50] and for Dukes C, 3.57 (95% CI 2.22-5.75) when compared with Dukes A patients. For the left colon, RR was 0.96 (0.61-1.52) and for the rectum 1.87 (1.22-2.86) when compared with the right colon. When adjusting for these factors and excluding operative mortality, RR for transfused patients was 1.16 (95% CI 0.87-1.55). It is concluded that blood transfusion does not adversely affect survival in colorectal cancer patients.